Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Therapy01:28

Drug Therapy

296
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
296
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.3K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.3K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.4K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.4K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

3.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

685
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
685
C4 Pathway and CAM01:27

C4 Pathway and CAM

49.2K
Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
49.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Enhanced variants of the Musk Ox Optimizer for global optimization problems.

Scientific reports·2026
Same author

Corrigendum to "Genomic surveillance of SARS-CoV-2 and emergence of XBB.1.16 variant in Rajasthan" [Indian J Med Microbiol 50 (2024) 100659].

Indian journal of medical microbiology·2026
Same author

Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.

Current pharmaceutical design·2026
Same author

Identification of condition-specific optimal reference genes for qPCR data normalisation in pink bollworm Pectinophora gossypiella (Saunders).

Molecular biology reports·2026
Same author

Genomic Surveillance of SARS-CoV-2 Variants Circulating in Rajasthan in 2025.

Cureus·2026
Same author

Engineering bioinspired pH-responsive hydrogels for smart wound repair.

Nanoscale·2026

相关实验视频

Updated: Feb 4, 2026

A Gut-on-a-Chip Model to Study the Gut Microbiome-Nervous System Axis
09:18

A Gut-on-a-Chip Model to Study the Gut Microbiome-Nervous System Axis

Published on: July 28, 2023

3.5K

通过肠道微生物组调节药物反应:通往精密治疗的途径

Nitish Kumar1, Joy Das2, Murugesan Vanangamudi3

  • 1SRM Modinagar College of Pharmacy, SRM Institute of Science and Technology (Deemed to be University), Delhi-NCR Campus, Modinagar, Ghaziabad, Uttar Pradesh, 201204, India.

Archives of microbiology
|February 2, 2026
PubMed
概括

肠道微生物组显著影响药物的疗效和新陈代谢. 了解这些肠道微生物群与药物相互作用对于开发个性化药物和改善治疗结果至关重要.

关键词:
药物影响 药物影响药物代谢药物代谢我们的肠道微生物组.个性化医疗是个性化的医疗.

更多相关视频

Application of Flow Vermimetry for Quantification and Analysis of the Caenorhabditis elegans Gut Microbiome
08:38

Application of Flow Vermimetry for Quantification and Analysis of the Caenorhabditis elegans Gut Microbiome

Published on: March 31, 2023

1.2K
Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device
10:51

Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device

Published on: August 30, 2016

23.6K

相关实验视频

Last Updated: Feb 4, 2026

A Gut-on-a-Chip Model to Study the Gut Microbiome-Nervous System Axis
09:18

A Gut-on-a-Chip Model to Study the Gut Microbiome-Nervous System Axis

Published on: July 28, 2023

3.5K
Application of Flow Vermimetry for Quantification and Analysis of the Caenorhabditis elegans Gut Microbiome
08:38

Application of Flow Vermimetry for Quantification and Analysis of the Caenorhabditis elegans Gut Microbiome

Published on: March 31, 2023

1.2K
Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device
10:51

Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device

Published on: August 30, 2016

23.6K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 环境微生物学 环境微生物学
  • 微生物组研究 微生物组研究

背景情况:

  • 肠道微生物组在宿主新陈代谢和药物作用中起着至关重要的作用.
  • 药物的疗效和宿主健康受到肠道微生物组成的影响.
  • 制药剂可以改变肠道微生物组的结构和功能.

研究的目的:

  • 审查药理学和环境微生物学之间的复杂关系.
  • 突出肠道微生物群对药物疗效和新陈代谢的影响.
  • 强调肠道微生物群与药物相互作用在个性化医学中的重要性.

主要方法:

  • 文献综述专注于肠道微生物群和药物之间的相互作用.
  • 对检查肠道微生物药物代谢的研究进行分析.
  • 探索制药剂如何影响微生物群落.

主要成果:

  • 肠道微生物群显著影响药物代谢和疗效.
  • 微生物衍生代谢物可以改变药物的作用和生理机制.
  • 由于肠道微生物群的差异,在不同人群中观察到药物反应的变化.

结论:

  • 肠道微生物组是药物反应和个性化治疗的关键因素.
  • 代谢学为理解复杂的肠道微生物群与药物相互作用提供了一种强大的方法.
  • 对这些相互作用的进一步研究可以提高治疗策略和患者的治疗结果.